<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">
Blogs

School of Medicine News and Stories

Artificial Intelligence (AI)

Research    Health equity    Artificial Intelligence (AI)

Mitigating AI Bias Goes Beyond the Data

The discussion around bias in artificial intelligence (AI) is no longer contained to data. Even the most impartial algorithm or analysis can encounter prejudice.  


Author Kara Mason | Publish Date July 17, 2023
Full Story

Research    Health equity    Artificial Intelligence (AI)

Do Chatbot Avatars Prompt Bias in Health Care?

Chatbots are increasingly becoming a part of health care around the world, but do they encourage bias? That’s what University of Colorado School of Medicine researchers are asking as they dig into patients’ experiences with the artificial intelligence (AI) programs that simulate conversation.


Author Kara Mason | Publish Date June 05, 2023
Full Story

School of Medicine In the News

CPR

Hospitals struggle to serve growing number of children in need of intensive mental health treatment

news outletCPR
Publish DateJuly 25, 2024

In Colorado and across the nation, emergency departments at pediatric hospitals are overflowing with kids who need intensive mental health treatment.

More News
9News

Colorado kidney donor set to compete in her 12th Ironman competition

news outlet9News
Publish DateJuly 23, 2024

A little more than a month after the Olympics wrap up, women triathletes will be heading to the south of France for another competition on the global stage.

More News
Healthy Debate

Medical education’s next frontier: Space

news outletHealthy Debate
Publish DateJuly 18, 2024

In 1961, Yuri Gagarin became the first human in space. With every kilometre he ascended, he pushed the boundaries of human achievement and catalyzed a surge of interest in exploration, research, development – and medical innovation.

More News
Medscape

As GLP-1 Demand Goes Up, Access and Coverage Go Down

news outletMedscape
Publish DateJuly 18, 2024

Experts debating the pressing issue of how to prioritize patients in the increasingly common scenario of loss of access or insurance coverage for anti-obesity glucagon-like peptide 1 (GLP-1) receptor agonist drugs argued that comorbidities and obesity severity should strongly warrant continued coverage — while offering key strategies for getting and retaining approval from payers.

More News